National Core for Neuroethics
|
February 24, 2014
On Wednesday March 12, there will be a panel discussion on how information about our brains is being stored and used today. The event takes place from 6:30-8:30pm at the Wosk Centre for Dialogue in Vancouver, and is part of the Brain Matters! Vancouver International Conference. Admission is free, but registration is required.
by Dirk Hanson
The Dana Foundation
|
January 23, 2014
Have we tipped too far in considering addiction a disease of only the brain, with no reference to the outside world? Some addiction researchers say yes.
by Bethany Brookshire
The Blog of the Presidential Commission for the Study of Bioethical Issues
|
December 18, 2013
In its review of ethical issues in neuroscience, the Bioethics Commission will "'consider how best to integrate ethics into neuroscience broadly–and the BRAIN Initiative specifically– but this Bioethics Commission will not be the ultimate locus of that integration.'"
by Daniel Freeman
The Guardian
|
December 13, 2013
Supposed differences between the brains of men and women are uncritically reported, while a very real disparity is ignored.
by Kayt Sukel
The Dana Foundation
|
December 12, 2013
Defendants are “blaming the brain” not only to mitigate sentences after conviction, but in their defense, of crimes from homicide to fraud. At the recent Society for Neuroscience annual meeting, Nita Farahany described the types of cases where neuro-evidence is already being used.
by Julie Haas
NeuroeEthics Women Leaders
|
December 12, 2013
A recap of the Science and Ethics of Moral Enhancement panel at November’s International Neuroethics Society meeting in San Diego.
See also
by Maggie Fox
NBC News
|
November 25, 2013
The FDA orders gene-testing company 23andMe to stop illegally selling its tests to diagnose disease.
by Andrew Kahn
Dana Foundation Blog
|
November 12, 2013
Panelists at an International Neuroethics Society event tackled complex and difficult questions about treating patients in a vegetative or minimally conscious state.
See also
by Ann Whitman
Dana Foundation Blog
|
November 10, 2013
Panelists at the International Neuroethics Society meeting weighed in on the questions: Can we create a morality pill? And if we can, should we?
See also
by Andrew Kahn
Dana Foundation Blog
|
November 8, 2013
Neurogaming was the topic at the International Neuroethics Society public program.
by Tom Valeo
The Dana Foundation
|
October 30, 2013
The philosopher-scientist has punctured quite a few of the sacred tenets of her fields. Churchland will be among the presenters at the International Neuroethics Society’s annual meeting, in San Diego on Nov. 7.
by Earl Lane
AAAS
|
October 28, 2013
A recap of the Neuroscience and Society event sponsored by the Dana Foundation and AAAS.
See also
by Niraj Chokshi
The Washington Post
|
October 21, 2013
The Supreme Court will be looking at state death penalty policies to answer the question: "How do you define whether someone’s sufficiently mentally disabled to avoid the death penalty?"
by Kayt Sukel
The Dana Foundation
|
October 10, 2013
We’ve heard a lot lately about brain-to-machine communication, and now there are first steps toward brain-to-brain communication. How do we prevent news of incremental discoveries from transporting our imaginations way too far?
by Jim Schnabel
The Dana Foundation
|
August 30, 2013
Laboratory demonstrations of “mind reading” with functional MRI have been increasingly impressive, but significant real-world applications are still years away.
by Helen Shen
Nature
|
August 14, 2013
Unsettling research advances bring neuroethics to the fore.
by Cordelia Fine
Neuroethics
|
August 1, 2013
A review of past fMRI studies of gender differences in the brain suggests that the reported results overhype the differences.
by Jason Castro
Scientific American
|
July 30, 2013
How neuroscientists can call up and change a memory.
by Roni Caryn Rabin
The New York Times
|
July 29, 2013
A push for early detection and treatment of Alzheimer's has some researchers worried.
by Nicky Penttila
Dana Foundation Blog
|
July 24, 2013
As neuroscience knowledge and technology advance, the need to predict and respond as a society to potential “fallout”—intrusions in mental privacy, unequal access to beneficial drugs—grows stronger, say panelists at a recent session on neuroethics in Washington, DC.
See also
by Matt Wall
Slate
|
July 16, 2013
The poor data and shoddy logic behind a hyped business boom.
See also
by Peter Stanford
The Telegraph
|
July 11, 2013
Dr. Kathleen Taylor talks to Peter Stanford ahead of her appearance at The Telegraph's Ways With Words festival about neuroscience, religious fundamentalism and that comment about brain surgery.
by Shirley S. Wang
Wall Street Journal
|
July 8, 2013
Studies of children with attention-deficit hyperactivity disorder find little change.
by Arthur Caplan
MIT Technology Review
|
June 18, 2013
Techniques that can soften or erase memories raise many ethical questions.
by Emily Bazelon
Slate
|
June 3, 2013
The Supreme Court just made it much easier for the government to collect genetic information.
Journal of Practical Ethics
|
June 1, 2013
Free access to the first issue of the Journal of Practical Ethics.
by Moheb Costandi
The Dana Foundation
|
May 20, 2013
Research suggests that non-invasive techniques such as transcranial magnetic stimulation and transcranial direct current stimulation might enhance sporting performance. This has not been confirmed yet, however, and even if it is, it would probably be considered as unacceptable as taking performance-enhancing drugs.
by Daniel Engber
Slate
|
May 13, 2013
How far should science go in making human-animal chimeras?
The Dana Foundation
|
Much of what we “know” from neuroscience research is not ready—yet—for use in the courtroom, argued panelists during a forum April 25 in Washington, DC. A webcast from the Neuroscience and Law series, sponsored by the Dana Foundation, AAAS, The MacArthur Foundation Research Network on Law and Neuroscience, and the International Neuroethics Society.
See also
by Pam Belluck and Benedict Carey
The New York Times
|
May 6, 2013
Just weeks before the long-awaited publication of a new edition of the so-called bible of mental disorders, the federal government’s most prominent psychiatric expert has said the book suffers from a scientific “lack of validity.” Dr. Thomas R. Insel, director of the National Institute of Mental Health, said his goal was to reshape the direction of psychiatric research to focus on biology, genetics and neuroscience so that scientists can define disorders by their causes, rather than their symptoms.
See also
by Stephen G. Lisberger
Cerebrum
|
May 2, 2013
By all accounts, scientific misconduct over the last decade is on the rise, especially in the area of journal retractions. In neuroscience, our author—both a leading academic and an experienced neuroscience journal editor—believes the field is detecting “only the tip of the fraud iceberg.” His story addresses the nature, detection, and incentives for fraud, and suggests reforms.
by Emma Moody and Rudi Stanislaus-Carter
British Association for Psychopharmacology
|
May 1, 2013
A Summary of the April 5 lecture given by Professor Barbara Sahakian at St. Andrews University.
NPR
|
April 30, 2013
An interview with psychologist Adrian Raine about his research into the biological roots of criminal behavior.
New York Academy of Sciences
|
April 26, 2013
The New York Academy of Sciences recently interviewed Professors Kent Kiehl and Owen Jones for a Science & the City Podcast. The podcast discussed “the developing role of neuroscience in the legal system” and focused on the recent PNAS publication, Neuroprediction of Future Rearrest.
by Nicky Penttila
Dana Foundation Blog
|
April 26, 2013
At a session at the American Association for the Advancement of Science (AAAS), panelists argued that neuroscience is not yet ready for the courtroom.
by Moheb Costandi
The Dana Foundation
|
April 25, 2013
Researchers are discovering medicines and methods that could enhance, dampen, or erase memories. At the recent BNA Festival of Neuroscience, ethicists and scientists considered the implications of modifying the mental record during a process called memory reconsolidation.
by Brenda Patoine
The Dana Foundation
|
April 10, 2013
In this briefing paper, neuroscientists express cautious enthusiasm about the hormone’s potential applications, but also warn of misperceptions brought on by oversimplified reporting.
by Regina Nuzzo
Nature
|
March 25, 2013
Neuroimaging 'biomarker' linked to rearrest after incarceration.
by Danielle Venton
PNAS First Look Blog
|
March 25, 2013
A new study suggests that fMRI can decode a person’s decision before he or she is even conscious of it.
See also
by Bill Glovin
Dana Foundation Blog
|
March 18, 2013
Failure of the media to communicate neuroscience is the focus of a four-person panel.
by Vaughan Bell
Mind Hacks
|
March 16, 2013
A Colorado judge allows the use of “truth serum” to support an insanity plea. “[T]he ‘narcoanalytic interview’ is so left-field as to leave some people scratching their heads as to whether the judge has been at the narcotics himself.”
by Carol Brayne, et al.
BMJ
|
February 27, 2013
A rallying call for an evidence based approach to dementia and related policy development.
by Michael Cook
BioEdge
|
February 23, 2013
President Obama’s announcement of the brain mapping project points toward investment in the field, but some neuroscientists worry that this one project will take funds away from other worthy studies.
by Brian Palmer
Slate
|
February 20, 2013
We are confused when we wake up. Could Oscar Pistorius use that as a defense?
Wall Street Journal
|
February 15, 2013
In this report, two doctors respond to the question.
Newswise
|
January 9, 2013
A study suggests that replacing prison terms with drug abuse treatment could save billions in criminal justice costs.
by Vaughan Bell
Mind Hacks
|
January 9, 2013
Increasingly, the DNA of individual killers is being studied in an attempt to tie violent behavior to genetics.
by Claudia Dreifus
The New York Times
|
December 17, 2012
An interview with neuroethicist S. Matthew Liao, director of the bioethics program at New York University.
by Judy Illes and Adrian Byram
Vancouver Sun
|
December 10, 2012
Opinion: Research has yet to offer definitive answers about brain-injured patients’ state of consciousness.
by Moheb Costandi
The Dana Foundation
|
December 4, 2012
What does it mean for society that use of smart drugs is increasing among cognitively healthy people?
by Emily Bazelon
Slate
|
November 28, 2012
After a challenge is dismissed by the Supreme Court this week, Idaho continues to not recognize the insanity defense for criminal conduct.
by Jorge Castillo
The Star-Ledger
|
November 27, 2012
A growing number of professional football players are testing positive for Adderall, commonly prescribed for attention deficit disorder, but listed as a banned substance by the NFL.
by Ray Kurzweil
Slate
|
November 16, 2012
Are you still you if devices improve your memory, attention span, and other cognitive skills?
by Jim Schnabel
The Dana Foundation
|
November 12, 2012
As research is showing that much of our decision-making—for good and ill—is unconscious, why not nudge people into making better choices rather than foisting rational arguments on them?
International Neuroethics Society
|
October 25, 2012
Watch panel discussions from the International Neuroethics Society annual meeting in mid-October.
by Nicky Penttila
Dana Foundation Blog
|
October 22, 2012
The responsibility for communicating science to the public starts with scientists, argued panelists at a social-issues roundtable during the recent Society for Neuroscience Annual Meeting.
by Ann Whitman
Dana Foundation Blog
|
October 17, 2012
In the final panel of the International Neuroethics Society annual meeting, scientists discussed the animal-machine models they’re using to further investigate motor function and learning.
by Ann Whitman
Dana Foundation Blog
|
October 16, 2012
At the International Neuroethics Society meeting, Dana Alliance member Charles O’Brien questioned whether ethical concerns are impeding treatment for addicts with criminal history.
by Alison Knopf
Addiction Treatment Forum
|
September 20, 2012
A recent example of the media exaggerating the results of a scientific study.
by Christian Jarrett
British Psychological Society's Research Digest
|
September 10, 2012
Research indicates that asking witnesses to close their eyes while recalling an event is a simple, yet effective way to improve eye-witness testimony.
by Kate Kelland
Reuters
|
August 29, 2012
The defense attorneys of a once respected Italian pediatrician accused of making sexual advances on his young patients argue that a brain tumor on the base of his brain caused his behavior to change. “It makes me wonder about the notion of responsibility,” says Dana Alliance member Colin Blakemore.
by Michael Laris
The Washington Post
|
August 26, 2012
Defense attorneys in a Maryland murder trial argue for submission of MRI lie-detector tests.
by Maia Szalavitz
TIME
|
August 17, 2012
Why judges hand down shorter sentences to convicted psychopaths when their behavior is blamed on the brain.
by Benedict Carey
The New York Times
|
August 16, 2012
Judges who were told that a defendant in a hypothetical case was genetically predisposed to violence imposed lighter sentences than they otherwise would have, researchers reported.
by Alexandra Topping
The Guardian
|
August 16, 2012
Tony Nicklinson, paralyzed below the neck and unable to speak, cannot have a doctor end his life, court rules.
by Chris French
The Guardian
|
August 10, 2012
Polygraphs are notoriously unreliable and easy to fool, and sooner or later sex offenders will discover the truth about them.
by Melissa Healy
Los Angeles Times
|
August 9, 2012
Should doctors be able to prescribe drugs approved by the FDA to treat a certain disease to patients suffering from an unrelated disease if clinical trials show some promise?
by Jonathan D. Moreno and Martha J. Farah
Science Progress
|
July 30, 2012
This primer gives a brief overview of hot topics on neuroethics, such as neuromarketing, criminal justice and the law, cognitive enhancement, intelligence and the military, and brain privacy.
by Moheb Costandi
The Dana Foundation
|
July 23, 2012
Deep brain stimulation, cell transplantation, and gene therapy offer hope of treatment or cure for a range of diseases but also raise serious ethical questions. Three experts offered their take on the issues during the William Safire lecture on Neuroethics at the recent European Federation of Neuroscience meeting in Barcelona.
See also
Trends in Neurosciences
|
July 19, 2012
Dana Alliance member Judy Illes discusses her career, including what led her to focus on neuroethics.
by Benjamin Weiser
The New York Times
|
July 19, 2012
Almost a year after a decision aimed at resolving the “troubling lack of reliability in eyewitness identifications,” the New Jersey Supreme Court issued instructions to help jurors better evaluate such evidence.
by Dan Harris, Lana Zak, and Dr Mark Abdelmalek
ABC News
|
July 17, 2012
A growing number of healthy people are taking the drug Provigil, approved for narcolepsy and sleep apnea, to improve their focus.
by Rebecca Goldin, Ph.D., Cindy S. Merrick
Statistical Assessment Service - STATS
|
July 16, 2012
In the first part of an ongoing series, STATS looks at functional magnetic resonance imaging, and whether it’s really the window on the mind that some in the media – and science – would have us believe.
by Rosie Mestel
Los Angeles Times
|
July 6, 2012
Ethical concerns are raised over the successful sequencing of human fetuses.
See also
by Carl Zimmer
Discover Magazine
|
June 15, 2012
Science writer Carl Zimmer digs into the science behind cognitive enhancement drinks (and tries some of them in the process).
by Matt Webb
July 6, 2012
A neuromarketing company relies on neuroscience hype to make the news.
by Cyd Cipolla
The Neuroethics Blog
|
June 21, 2012
Cyd Cipolla attended the Neuroscience, Law, and Ethics of Lie Detection Technologies Symposium in May and was left pondering the questions: “Who owns the thoughts in my head? Could I be compelled to submit them? Can someone else decide that keeping my ideas to myself is a violation of the law or a threat to my country? If they force me to surrender them, do I lose ownership?”
by Moheb Costandi
The Dana Foundation
|
June 19, 2012
As technology advances to the point where doctors can communicate to some extent with minimally conscious patients, what should they be asking? Simply, "Do you need another pillow?" Or, "Do you want to die?"
See also
Science Daily
|
June 18, 2012
The legal system needs to take greater account of new discoveries in neuroscience that show how a difficult childhood can affect the development of a young person's brain which can increase the risk adolescent crimes, according to researchers.
by Brian D. Earp, Julian Savulescu, and Anders Sandberg
Practical Ethics
|
June 14, 2012
Love drugs and science reporting in the media: Setting the record straight.
by Alan Schwarz
The New York Times
|
June 9, 2012
At high schools across the United States, pressure over grades and competition for college admissions are encouraging students to abuse stimulants.
by Moheb Costandi
The Guardian
|
May 30, 2012
Should amputation be offered as a treatment to people suffering from Body Integrity Identity Disorder?
by Vaughan Bell
The Guardian
|
April 21, 2012
'Lie detectors' are highly fallible, yet suspects are more likely to tell the truth when wired up to them. So should we trust this flawed technology?
by Wolfgang Stroebe
Scientific American
|
April 20, 2012
Can subliminal advertisements influence our behavior? New research says yes—but only under certain circumstances.
by Ewen Callaway
Nature
|
April 17, 2012
Pioneering clinical genome-sequencing projects focus on patients with developmental delay.
by Ed Yong
Discover Magazine
|
April 9, 2012
A look at the current state of lie-detection. Existing devices are far from perfect, yet they are already used in trials "with varying success."
by Alan Boyle
NBC News
|
March 27, 2012
An fMRI study from Japan's National Institute of Radiological Sciences looks for brain regions associated with sympathy in jurors’ brains.
by Michael N. Tennison and Jonathan D. Moreno
PLOS Biology
|
March 20, 2012
Mind Wars author and U. Penn Professor Jonathan Moreno and Wake Forest Professor Michael N. Tennison discuss the ethical issues that arise from the close funding relationship between the Department of Defense and the neuroscience community.
The Chronicle of Higher Education
|
March 18, 2012
Dana Alliance member Michael Gazzaniga is one of seven authors featured in a round-up of articles about the notion of free will.
by Nicky Penttila
Dana Foundation Blog
|
February 29, 2012
Our memories are not like DVRs, so it’s no surprise that eyewitnesses sometimes point out the wrong person. At the recent AAAS conference, a retired judge described how police collect such testimony—and what they might do to improve its accuracy.
by Olivier Oullier
Nature
|
February 29, 2012
France has banned commercial applications of brain imaging. So why approve its use in court?
by Charles Duhigg
The New York Times Magazine
|
February 16, 2012
Retailers study our individual shopping habits to better market their products.
The Royal Society
|
February 7, 2013
The Royal Society has released this report which “considers some of the potential military and law enforcement applications arising from key advances in neuroscience.” The report is available for download in PDF, as well as in versions compatible with Kindle and e-readers (EPUB).
by Ross Andersen
The Atlantic
|
February 6, 2012
Interview with ethicist Allen Buchanan on cognitive enhancement.
by Gary Stix
Scientific American
|
February 6, 2012
Are these relatively simple electric shock treatments too good to be true?
The Telegraph
|
January 26, 2012
Tiny electric shocks can boost the brain’s performance in healthy adults.
See also
by Alvaro Fernandez
SharpBrains
|
January 6, 2012
SharpBrains’ co-founder and Chief Executive Officer Alvaro Fernandez argues that “to improve the ethics of the brain fitness business and its application (and empower consumers’ informed decision making), there must first be agreement about a meaningful, appropriate way to analyze and guide innovation.”
by Ann Parson
The Dana Foundation
|
December 20, 2011
Neuromarketing, the practice of using neuroscience to try to determine a person’s unconscious biological reactions to a product, is here to stay, but whether it works is much harder to prove.
The Royal Society
|
December 13, 2011
The Royal Society has released a report on the growing relationship between neuroscience research and the legal system. The report is available for download in PDF, as well as in versions compatible with Kindle and e-readers (EPUB).
by Maria Cheng
Associated Press (via San Francisco Chronicle)
|
December 18, 2011
Noting that brain imaging is increasingly being used in U.S. trials, a study from the Royal Society in England reports that "it's too soon for the law to be swayed by scientists' understanding of the brain.”
by Gary Stix
Scientific American
|
December 14, 2011
Scientific American reports from the SUNY Downstate symposium on neuroethics and memory.
by Moheb Costandi
The Dana Foundation
|
December 13, 2011
Researchers can describe differences in the brains of psychopaths, addicts, and developing humans (a k a teenagers), compared with normally behaving adults. But no one is ready to predict a person's behavior based on a brain scan, warned panelists during a public symposium at the recent Society for Neuroscience annual meeting.
by Tayler Cattera
Western Herald
|
December 5, 2011
A report on the keynote lecture at Western Michigan University’s recent philosophy conference, which was given by Dr. Walter Sinnott-Armstrong, Chauncey Stillman Professor of Practical Ethics at Duke University. The lecture addressed neural detection of consciousness, criminal responsibility, and neuroprediction.
by Laura Beil
The New York Times
|
November 28, 2011
Another examination of witness testimony in the court system, a topic being reviewed by the Supreme Court this month.
by Heather E. Douglas
The Scientist
|
November 16, 2011
Heather Douglas, Waterloo Chair in Science and Society at the University of Waterloo, debates the question, “[A]re scientists responsible for the potentially negative impacts of their work?”
That’s Basic Science Blog
|
November 16, 2011
Commentary on the Society for Neuroscience panel The Brain on Trial: Neuroscience and the Law, featuring Drs. Craig Stark, Adrian Raine, Abigail Baird, and Steven E. Hyman. Video of the talk included.
by Michael Gazzaniga
Slate
|
November 15, 2011
An excerpt from Dr. Gazzaniga’s new book, Who’s in Charge?: Free Will and the Science of the Brain.
by Ann Whitman
Dana Foundation Blog
|
November 14, 2011
At the International Neuroethics Society meeting’s final panel, two lawyers and a neurologist talked about the role imaging evidence played in landmark trials in which they participated.
by Nicky Penttila
The Dana Foundation
|
November 11, 2011
During a workshop at the annual meeting of the International Neuroethics Society, panelists advised ethical wannabes to just get started.
by Benedict Carey
The New York Times
|
November 9, 2011
Using a relatively common EEG test, doctors found that three patients, believed to be in vegetative states, showed signs of full consciousness.
Logarchism
|
November 2, 2011
The Supreme Court weighs in on longstanding standards for eyewitness testimony.
See also
by Nicholas Jackson
The Atlantic
|
October 7, 2011
Jonathon Moreno explains what it means to be a bioethicist and discusses new trends in the field. These topics and more are covered in his new book, The Body Politic: The Battle Over Science in America.
by Neil Levy
The Conversation
|
October 6, 2011
Neuroethicist Neil Levy, Florey Neuroscience Institutes, discusses the role of responsibility in drug addiction.
by Arthur Caplan, Ph.D.
NBCNEWS.com
|
September 30, 2011
Despite new findings that people with down syndrome and their families have reported an “overwhelmingly positive quality of life,” bioethicist Arthur Caplan believes most parents will still elect to end pregnancies where down syndrome is detected.
See also
by Amanda Lee Myers and Jacques Billeaud
September 28, 2011
After showing improvement from medication forcibly administered to treat his schizophrenia, Jared Loughner is ruled by a federal judge to “eventually be made mentally fit to stand trial.”
See also
The Daily Mirror
|
September 28, 2011
A UK High Court judge rules against a family’s request to withdraw life-support treatment for a brain-damaged, minimally conscious woman.
Nature
|
September 22, 2011
In a Nature special, the journal offers several articles about the relationship between science and the military
by Brenda Patoine
The Dana Foundation
|
September 19, 2011
Dana grantee Charles P. O’Brien works with parolees who have a history of addiction and relapse. His research using naltrexone to combat alcoholism and drug addiction has shown good results, but he is frustrated at the reluctance of many doctors to treat addiction with medication. He hopes his research “will convince judges, prosecutors, and parole officers that naltrexone will help addicts stay off drugs, help prisons empty out a bit, and save a lot of money.”
by Caitlin Schneider
Dana Foundation Blog
|
September 15, 2011
Researchers at Yale University are testing the hypothesis that people are innately biased towards good or evil.
by Brian Owens
Nature News Blog
|
September 1, 2011
A convicted murderer in Italy, deemed mentally ill, has her sentence reduced based on neuroimaging data.
See also
by Michael Stobbe
Associated Press (via Yahoo)
|
August 30, 2011
New details are released about the 1940s medical experiments carried out by the U.S. Public Health Service, Pan American Sanitary Bureau, and a number of Guatemalan government agencies on unknowing Guatemalans.
by Erica Goode and John Schwartz
The New York Times
|
August 28, 2011
New Jersey's Supreme Court ruling on eye witness identifications could change the way police conduct future investigations.
TMCnet
|
August 23, 2011
The American Association for the Advancement of Science issues a release about the first Capitol Hill Briefing, held July 26 and sponsored by the Dana Foundation. The session focused on military applications of neuroscience, and featured Dana Alliance members such as Martha Farah, Alan Leshner, and Jonathan Moreno.
by Jennifer Welsh
LiveScience
|
August 17, 2011
Despite ethical concerns, one researcher advocates for the use of memory-altering drugs in treatment for conditions such as post-traumatic stress disorder.
by Torie Bosch
Slate
|
August 4, 2011
With Hollywood films taking on futuristic brain-boosting in Rise of the Planet of the Apes and Limitless, one writer asks the question, “What kind of neuroenhancers are actually in the real-world pipeline right now?”
by Michelle Hutchinson
Practical Ethics Blog
|
July 30, 2011
The University of Oxford’s blog, Practical Ethics, addresses the recent report from the Academy of Medical Sciences, which examines “the use of animals containing human material (ACHM) in scientific research.”
by Arthur Caplan
MSNBC.COM
|
June 27, 2011
Dana Alliance member Arthur Caplan, Ph.D., director of the Center for Bioethics at the University of Pennsylvania explains why he thinks that Jared Loughner should be forcibly medicated to stand trial.
Practical Ethics
|
June 9, 2011
The University of Oxford’s Practical Ethics blog announces the launch of a new neuroethics blog in collaboration with the International Neuroethics Society.
by Kayt Sukel
The Dana Foundation
|
May 24, 2011
In this Dana Foundation briefing paper, neuroethics experts discuss how advances in neuroscience may help defense attorneys who represent mentally ill clients.
by Elizabeth Lopatto
Bloomberg
|
May 12, 2011
Doctors may be able to tell whether a patient is in a vegetative or minimally conscious state by tracking signals on a path through the brain, a study said.
International Business Times
|
May 10, 2011
Could the scientific discoveries of recent decades about how the brain works also be used to improve the functioning of healthy individuals?
Brain Posts
|
May 5, 2011
This second part of Brain Posts’ three-part summary of the May 2011 Warren Frontiers in Neuroscience lecture looks at the brain and religious beliefs.
Brain Posts
|
May 4, 2011
Brain Posts blog offers a three-part summary of the May 2011 Warren Frontiers in Neuroscience lecture, titled “Brain Regions Supporting the Establishment of Human Beliefs.” Presented by Dana Alliance member Jordan Grafman, the lecture was divided into three parts: moral beliefs, religious beliefs, and political beliefs.
by Tobias Skuban, Katja Hardenacke, Christiane Woopen, and Jens Kuhn
Frontiers in Integrative Neuroscience
|
April 29, 2011
Skuban et al. discuss concerns associated with patient consent for deep brain stimulation, particularly in cases where the procedure is being used to treat psychiatric disorders.
by Caroline Perry
Harvard Gazette
|
April 21, 2011
A symposium held on April 14 addressed the question can privacy, individual autonomy, and scientific enterprise coexist?
by Jeremy Laurance
The Independent
|
April 15, 2011
Using the movie “Limitless” as a jumping off point for a discussion on “smart drugs,” writer Jeremy Laurance explores the boundary between therapy and enhancement.
by Michael Gazzaniga
Scientific American Mind
|
April 13, 2011
Dana Alliance member Michael Gazzaniga explains how neurological evidence can affect the outcome of criminal cases even if juries never hear it.
by Kyle Munkittrick
Discover
|
April 7, 2011
Discover blogger Kyle Munkittrick addresses recent news about mood altering drugs and whether or not these drugs can eventually be used to create a more moralistic society. He argues that while “mood creates conditions conducive to moral behavior. Mood does not determine moral behavior.”
Cell Press Neuroscience Newsletter
|
Listen to Martha Farah, director of the Center for Cognitive Neuroscience at the University of Pennsylvania, discuss the the current state of neurolaw and the legal implications of neuroscientific research.
by David Eagleman
The Telegraph
|
April 5, 2011
Neuroscientist David Eagleman explains how brain research could lead us to create a better legal system.
by Nicky Penttila
Dana Foundation Blog
|
April 4, 2011
Following up on Guy McKhann's recent Brain in the News column and the Dana Foundation’s news story on deep brain stimulation to treat Tourette's, Nicky Penttila blogs about the controversy among neuroscientists on how quickly to extend the procedure to other psychiatric illnesses.
See also
by Amelia Hill
Guardian
|
April 4, 2011
Drugs that impact moral behavior already exist, and scientists predict that future research may lead to even more sophisticated manipulations.
by Nicky Penttila
March 18, 2011
Neuroscience findings offer tantalizing clues to our behavior, but in most cases they aren't specific or individual enough to introduce into court. Lawyers, judges, and scientists discussed the present and looked to the future at a recent Law & the Brain forum in New York.
3/18/11
Judy Illes, the Canada Research Chair in Neuroethics at the University of British Columbia, discusses how she has successfully used Brain Awareness Week as a platform to increase interest in neuroethics.
by Alok Jha
The Observer
|
March 13, 2011
Paul Fairchild, co-director of the newly founded Oxford Stem Cell Institute, discusses his vision for the coming, post-hype decade of stem cell science.
by Jesse Bering
Slate
|
March 3, 2011
Slate writer Jesse Bering discusses several cases where brain injury or disease led people to exhibit hypersexualized behavior, in some instances leading to criminal acts.
by Matt Lamkin
The Chronicle of Higher Education
|
February 27, 2011
College campuses struggle to address the increasing use of performance enhancement drugs, such as Ritalin, by healthy students. Matt Lamkin argues that schools need to restore “a culture of deep engagement in education, rather than just competition for credentials.”
by Benedict Carey
The New York Times
|
February 14, 2011
Arguing that “commercial interest has been working to push D.B.S. into the psychiatric market ahead of the science,” prominent researchers voice concern over surgical treatments for obsessive compulsive disorder.
by Julie M. Robillard and Judy Illes
Vancouver Sun
|
February 14, 2011
Drs. Robillard and Illes discuss the challenges of treating patients with dementia.
by Brigid O'Connell
Herald Sun
|
February 13, 2011
Oxford professor Julian Salvulescu advocates using IVF to select the smartest embryos, despite the possibility that this practice could increase social inequalities.
by Jim Schnabel
February 3, 2011
Twenty research volunteers who received electrical stimulation of the anterior temporal lobes were three times as likely to reach the fresh insight necessary to solve a difficult, unfamiliar problem as were those in a control group, according to a new study.
by Moheb Costandi
January 20, 2011
Scientists who do research on groups outside their culture shouldn't assume their subjects share the same beliefs or worldview, said a panelist during the Neuroethics Society's annual meeting.
Donald Pfaff, Ph.D., head of the Laboratory of Neurobiology and Behavior at Rockefeller University, gives us a science-based hypothesis of why humans across time and geography have such similar notions of right and wrong.
See also
by Walter Glannon, Ph. D., editor
Contributors include Adina Roskies on neuroethics for the New millennium, Martha J. Farah and Paul Root Wolpe on monitoring and manipulating brain function, Antonio Damasio on the neural basis of social behavior, and Alan Leshner on ethical issues in taking neuroscience research from bench to bedside.
See also